Initiates distribution of SCoV-2 Ag Detect Self-Test to consumers in the United States and expansion of SURE CHECK HIV Self-Test distribution to consumers in Brazil and the United Kingdom

HAUPPAUGE, N.Y., June 15, 2022 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the launch of its direct-to-consumer commercial channel for the third-party SCoV-2 Ag Detect Self-Test in the U.S. market. In addition, Chembio is expanding distribution of its SURE CHECK HIV Self-Test to consumers in Brazil and the United Kingdom by broadening the test kit’s existing Over-the-Counter (OTC) availability in national pharmacy chains.

“We are excited to expand patient access to rapid, accurate and easy to use at home diagnostics across the United States, Brazil and the United Kingdom,” said Richard Eberly, Chembio’s Chief Executive Officer and President. “We are now offering the SCoV-2 Ag Detect Self-Test via our distribution network and directly through Chembio in the US. In addition, we are now offering our SURE CHECK HIV Self-Test through e-commerce platforms in the UK and Brazil. This commercial expansion increases our addressable market and is intended to enable deeper penetration of the market as at home testing volumes continue to grow. This initiative directly aligns with our goal to focus on higher margin business in growing markets under our Global Competitiveness Program.”

Customers can obtain more information related to the SCoV-2 Ag Detect Self-Test and the SURE CHECK HIV Self-Test at www.chembio.com.

About SCoV-2 Ag Detect Self-Test
The SCoV-2 Ag Detect Self-Test will launch in the U.S. in June, with distributors servicing the OTC market and Chembio simultaneously beginning to accept direct customer orders. The SCoV-2 Ag Detect™ Self-Test, manufactured by InBios International, Inc., is a rapid immunoassay test for the detection of SARS-CoV-2 antigens that provides results in 20 minutes from a nasal swab and requires no instrumentation. The product is cleared for OTC use under an Emergency Use Authorization issued by the U.S. Food and Drug Administration.

About SURE CHECK HIV Self-Test
The direct-to-consumer initiative for the Chembio’s SURE CHECK HIV Self-Test will launch in Brazil through a third-party e-commerce partner and in the United Kingdom via Amazon in July. The SURE CHECK HIV Self-Test is a single-use in-vitro diagnostic self-test that detects antibodies to HIV-1 and HIV-2 from a 2.5 µl fingerstick whole blood sample. The SURE CHECK HIV Self-Test is currently being marketed in Brazil under ANVISA approval and in the United Kingdom under a CE Mark.

Subscribe to the Chembio Mailing List